
Opinion|Videos|November 21, 2024
Telehealth and Research Strides for Young Patients
Author(s)Lisa Swanson, MD, FAAD
Key Takeaways
- Telemedicine and digital health tools enable remote consultations, improving management and follow-up care for pediatric vitiligo patients by reducing the need for frequent in-person visits.
- Emerging research aims to understand vitiligo pathogenesis, focusing on immune modulation, genetic factors, and novel drug targets to develop therapies that halt or slow disease progression.
Lisa Swanson, MD, discusses how telemedicine and digital health tools can aid in the management and follow-up care of pediatric patients with vitiligo by enabling remote monitoring, improving access to specialists, and facilitating patient engagement, while emerging research into vitiligo treatments may focus on developing therapies to halt or slow the progression of this autoimmune skin condition.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How do you see advancements in telemedicine or digital health tools aiding in the management and follow-up care of pediatric vitiligo patients?
- In terms of future treatments, what emerging research might focus on halting or slowing the progression of the disease?
Advertisement
Related to this article

The FDA clearance allows Edesa to expand an ongoing placebo-controlled study of the CXCL10 antibody EB06 to US sites, with topline data expected in the fourth quarter of 2027.
Advertisement
Advertisement
Trending on Dermatology Times
1
Social Media Mythbusters: Can Castor Oil Really Grow Hair?
2
Bitopertin Meets All End Points in Phase 3 APOLLO Trial for EPP
3
EADV 2026 Atopic Dermatitis Highlights: Tilrekimig, RAC2 Inhibition, and Level Up Data
4
FDA Approves Pritelivir for Refractory Mucocutaneous HSV in Immunocompromised Adults
5






